“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
North Korean shoots officers, defects to South Korea
Supreme Court increases immunity for police who kill fleeing suspects
Sen. Lindsey Graham to seek authorization for U.S. attack on Iran
WTC memorial magnificent, but at a steep price
Tech Renegade: From Print-at-Home Guns to Untraceable Currency
Jim Bovard: The great farm robbery
Obama quietly extends post-9/11 state of national emergency
German pilot in WWII and American B-17 pilot he spared reunite 40 years later
Here’s what critics miss about Bitcoin’s long-term potential
Water rationing, tax and rate hikes add to woes of Puerto Ricans
Bored With Banking, This Former Citi Trader Went Full Crypto
Antarctica once covered in palm trees, scientists discover
India Bans Bitcoin But Embraces Blockchain
Warren Buffett's bubble cash-out strategy revealed in 38-year-old letter
Chinese official jumps to his death after garbage landslide kills dozens